Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Cambrex é reconhecida com prêmio CMO Leadership Awards de 2022 pelo oitavo ano consecutivo
  • Latin America - español
  • USA - English
  • USA - español
  • USA - Deutsch
  • India - English
  • USA - Français

Cambrex Logo

News provided by

Cambrex

Feb 08, 2022, 09:30 ET

Share this article

Share toX

Share this article

Share toX

EAST RUTHERFORD, Nova Jersey, 8 de fevereiro de 2022 /PRNewswire/ -- A Cambrex, empresa líder global em desenvolvimento e fabricação mediante contrato (CDMO), anunciou hoje que foi reconhecida pelo CMO (empresa de fabricação mediante contrato) Leadership Awards nas categorias de qualidade e serviço. O reconhecimento marca o oitavo ano consecutivo em que a Cambrex é premiada.

"A Cambrex tem a honra de ser identificada mais uma vez por nossos clientes e colegas do setor como fornecedora líder do setor farmacêutico. O fato de sermos reconhecidos nas categorias de qualidade e serviço reflete nossa competência técnica e nossa abordagem de oferecer soluções personalizadas com foco nas necessidades de nossos clientes", disse Thomas Loewald, CEO da Cambrex. Ele acrescentou: "A demanda pelo desenvolvimento e fabricação terceirizados de produtos farmacêuticos está crescendo continuamente. Na Cambrex, temos o compromisso de investir na capacidade, recursos e conhecimentos necessários para fortalecer nossa posição como CDMO líder global."

Os resultados da premiação CMO Leadership Awards baseiam-se em pesquisas primárias de mercado provenientes das pesquisas on-line anuais Contract Manufacturing Quality Benchmarking (análise comparativa anual de qualidade de fabricação) da Industry Standard Research. Para o prêmio CMO Leadership Awards de 2022, 86 CMOs foram avaliados em 23 métricas de desempenho. Os participantes da pesquisa foram recrutados de empresas biofarmacêuticas de todos os tamanhos e foram avaliados quanto à influência e autoridade na tomada de decisões quando se trata de trabalhar com CMOs. Os entrevistados avaliaram apenas empresas com as quais haviam trabalhado em um projeto terceirizado nos últimos 18 meses. Esse nível de qualificação assegura que as classificações vêm do envolvimento real com um negócio e que as empresas identificadas como líderes são respaldadas por dados experimentais. As CMOs devem atender ao limite mínimo de respostas à pesquisa do cliente para serem elegíveis para um prêmio.

"Parabéns a todos os ganhadores do CMO Leadership Award de 2022 da Life Science Leader e da Outsourced Pharma", anunciou Louis Garguilo, editor-chefe e presidente de conferências da Outsourced Pharma. "Vocês são os principais provedores de serviços do setor biofarmacêutico, aqueles que se superaram por seus clientes em meio aos obstáculos impostos pela pandemia, desafios da cadeia de suprimentos e aumento das demandas por novas plataformas e tecnologias."

A Cambrex comemorou recentemente o 40º aniversário de sua fundação em 1981. Após quarenta anos de crescimento e transformação em uma empresa líder global em desenvolvimento e fabricação mediante contrato (CDMO), a Cambrex continua seu compromisso com a liderança na fabricação de fármacos, com mais de USD 100 milhões em investimentos que estão sendo realizados em sua rede global de fabricação.

Sobre a Cambrex 

A Cambrex é uma empresa líder global em desenvolvimento e fabricação mediante contrato (CDMO) que presta serviços analíticos, de fármacos e produtos medicamentosos em todo o ciclo de vida do medicamento. Com mais de 40 anos de experiência e uma equipe crescente de mais de 2.200 especialistas atendendo clientes globais da América do Norte e da Europa, a Cambrex é uma parceira de confiança em mercados de marca e genéricos para o desenvolvimento e fabricação de APIs e formas de dosagem.

A Cambrex oferece uma série de tecnologias e recursos especializados de fármacos, inclusive biocatálise. Fluxo contínuo, substâncias controladas, ciência de estado sólido, caracterização de materiais e APIs altamente potentes. Além disso, a Cambrex pode suportar formas de dosagem convencionais, incluindo sólidos, semissólidos e líquidos orais, e tem experiência na fabricação de formas de dosagem especiais como comprimidos de liberação modificada, combinação de dose fixa, pediátrica, comprimidos de duas camadas, stick packs, produtos tópicos, substâncias controladas, pomadas estéreis e não estéreis.

Para mais informações, acesse http://www.cambrex.com

Sobre o CMO Leadership Awards 

Agora em seu 11º ano, o prêmio CMO Leadership Awards da Outsourced Pharma e Life Science Leader oferece aos leitores avaliações precisas e confiáveis dos clientes para ajudá-los a escolher um parceiro com boa reputação para suas necessidades de desenvolvimento e fabricação. Para o CMO Leadership Awards de 2022, a Industry Standard Research (ISR) determinou os ganhadores do prêmio por meio de sua avaliação de mais de 86 fabricantes mediante contrato. Essas CMOs foram avaliadas em 23 métricas de desempenho na pesquisa anual Contract Manufacturing Quality Benchmarking da ISR.

Logotipo - https://mma.prnewswire.com/media/1723116/Cambrex_40_Years_Logo.jpg

FONTE Cambrex

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

Cambrex expandirá la fabricación de API y fortalecerá el suministro de medicamentos en EE. UU.

Cambrex expandirá la fabricación de API y fortalecerá el suministro de medicamentos en EE. UU.

Cambrex, una organización líder mundial en desarrollo y fabricación por contrato (CDMO), anunció hoy una inversión de 120 millones de dólares para...

Cambrex dévoile un investissement de 120 millions de dollars pour développer la fabrication d'IPA et renforcer la résilience de l'approvisionnement en médicaments aux États-Unis

Cambrex dévoile un investissement de 120 millions de dollars pour développer la fabrication d'IPA et renforcer la résilience de l'approvisionnement en médicaments aux États-Unis

Cambrex, une organisation mondiale de développement et de fabrication sous contrat (CDMO) de premier plan, a annoncé aujourd'hui un investissement de ...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Biotechnology

Biotechnology

Pharmaceuticals

Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.